Predictors of high Killip class after ST segment elevation myocardial infarction in the era of primary reperfusion

Lourdes Vicent1, Jesús Velásquez-Rodríguez1, María Jesús Valero-Masa1

  • 1Servicio de Cardiología, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERCV, Madrid, Spain.

Insights

Predictors of high Killip class in ST-segment elevation myocardial infarction (STEMI) patients were identified. Early identification of high-risk STEMI patients using these variables can improve in-hospital prognosis.

Area of Science:

  • Cardiology
  • Intensive Care Medicine
  • Clinical Research

Background:

  • ST-segment elevation myocardial infarction (STEMI) outcomes have improved, yet high Killip class patients still face poor prognosis.
  • Patients with Killip class II or higher require closer monitoring in specialized cardiac care units.

Purpose of the Study:

  • To determine independent predictors of Killip class in patients admitted with acute STEMI.
  • To identify factors associated with elevated Killip class in STEMI patients.

Main Methods:

  • A non-interventional registry study was conducted in a Cardiac Intensive Care Unit.
  • 1111 patients admitted for acute STEMI between January 2010 and April 2015 were included.
  • Multivariate analysis was performed to identify independent predictors of high Killip class (≥II).

Main Results:

  • 20.7% of patients were classified as Killip class II or higher.
  • Independent predictors of Killip class ≥II included older age, female sex, diabetes, prior heart failure, chronic kidney disease, anemia, multivessel disease, anterior STEMI location, prolonged symptom onset to treatment time (>2h), and low TIMI flow grade (<3).
  • In-hospital mortality significantly increased with higher Killip class.

Conclusions:

  • Killip class in STEMI patients can be predicted using variables available at the time of primary percutaneous coronary intervention.
  • Predicting Killip class is strongly associated with in-hospital prognosis for STEMI patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.2K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
316
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
321
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
969
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
494